Yahoo Finance • 22 days ago
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Maravai (MRVI) To Contact Him Directly To Discuss Their Options If you purchased or acquired common stock in Maravai LifeSciences be... Full story
Yahoo Finance • 2 months ago
Earnings Call Insights: Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2025 MANAGEMENT VIEW * CEO Bernd Brust opened his first earnings call by noting, "I came into this role with a clear understanding that realizing Maravai's full pote... Full story
Yahoo Finance • 2 months ago
Announced organizational restructuring and operating cost reduction initiatives targeting more than $50 million in annualized cost savings Quarterly base business revenue, which excludes revenue from high-volume CleanCap® for commercializ... Full story
Yahoo Finance • 2 months ago
SAN DIEGO, July 28, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2025 fi... Full story
Yahoo Finance • 2 months ago
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) announced Friday that its Audit Committee has approved the appointment of Deloitte & Touche LLP as the company’s independent registered public accounting firm for the fiscal year ending Dec... Full story
Yahoo Finance • 2 months ago
SAN DIEGO, July 18, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, is investigating potential violations of federal and state securities laws by certain officers and directors of Quantum Computing Inc. (NASDAQ: QUBT), AppLovin Corporatio... Full story
Yahoo Finance • 3 months ago
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Maravai (MRVI) To Contact Him Directly To Discuss Their Options If you purchased or acquired common stock in Maravai LifeSciences be... Full story
Yahoo Finance • 3 months ago
SAN DIEGO, July 02, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP is investigating potential violations of federal and state securities laws by certain officers and directors of the following companies: Quant... Full story
Yahoo Finance • 3 months ago
Investing.com - William Blair maintained its Market Perform rating on Maravai LifeSciences Holdings Inc. (NASDAQ:MRVI) Tuesday following significant leadership changes at the company. According to InvestingPro data, the company’s shares ha... Full story
Yahoo Finance • 3 months ago
* Maravai LifeSciences (NASDAQ:MRVI [https://seekingalpha.com/symbol/MRVI]) announced that Rajesh Asarpota has been appointed executive vice president and chief financial officer effective June 30, 2025. * He will succeed Kevin Herde,... Full story
Yahoo Finance • 3 months ago
SAN DIEGO, June 25, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that Rajesh “Raj” Asarpota ha... Full story
Yahoo Finance • 3 months ago
NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) on behalf of long-... Full story
Yahoo Finance • 5 months ago
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Maravai LifeSciences Holdings, Inc. ("Maravai LifeSciences" or the "Company") (NASDAQ: MRVI) of a class action securities lawsuit. CLASS DEFINITION:... Full story
Yahoo Finance • 5 months ago
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI). Such investors are advised to contac... Full story
Yahoo Finance • 5 months ago
LOS ANGELES, May 05, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the d... Full story
Yahoo Finance • 5 months ago
SAN FRANCISCO, May 05, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) reported its fourth-quarter 2024 earnings, missing analyst expectations and prompting a significant downward revision of its price target... Full story
Yahoo Finance • 5 months ago
SAN FRANCISCO, May 03, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) reported its fourth-quarter 2024 earnings, missing analyst expectations and prompting a significant downward revision of its price target... Full story
Yahoo Finance • 5 months ago
NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Maravai LifeSciences Holdings, Inc. ("Maravai LifeSciences" or the "Company") (NASDAQ: MRVI) of a class action securities lawsuit. CLASS DEFINITION:... Full story
Yahoo Finance • 5 months ago
NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI). Shareholders who purchased shares of MRVI during the class period listed ar... Full story
Yahoo Finance • 5 months ago
ATLANTA, May 01, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC reminds investors of the May 5, 2025 deadline to seek to be appointed lead plaintiff in the following class action lawsuits: AppLovin Corporation The shareholder class acti... Full story